India: +91-40-42023318 | Singapore: +65-31631880
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719


Clinical Trial News

Investigational immunotherapy was safe, tolerable, and showed some activity against melanoma

The investigational immunotherapeutic IMC-20D7S was safe, well tolerated, and showed signs of modest clinical activity for patients with advanced melanoma, according to results from a...

Positive pivotal Phase 3 data announced demonstrating investigational Elagolix reduced endometriosis-associated pain

AbbVie, a global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc.

Depression could be treated with anti-inflammatory drugs

A new meta-analysis finds a new class of drugs used to treat inflammation in autoimmune diseases may also be an effective treatment for depression.

The placebo effect: Knowingly taking sham pills may reduce chronic pain

New study suggests it is not the expectation that a 'dummy pill' is real that elicits the placebo effect, but rather the ritual associated with taking it.

Caffeine did not induce arrhythmia in trial with heart failure patients

A trial where heart failure patients ingested 500 mg caffeine over 5 hours found no raised risk of arrhythmic episodes, even during treadmill stress test.

Breast cancer drug shows potential in patients with skin metastases

A study presented at the ESMO Congress reveals how the drug tucatinib led to a reduction in skin metastases for patients with breast cancer.

Cabozantinib improves progression-free survival in metastatic renal cell carcinoma

Cabozantinib significantly improves progression-free survival and response rate in patients with metastatic renal cell carcinoma compared to sunitinib, according to research presented at the ESMO...

Custirsen shows no survival benefits in metastatic prostate cancer

A phase III randomized controlled trial of custirsen in combination with cabazitaxel/prednisone in patients with previously-treated metastatic, castration-resistant prostate cancer has shown no...

James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook